Graftless Lateral Sinus Lifting Using Peizo Electric Device in Patients With Atrophic Maxilla (NCT07753057) | Clinical Trial Compass
CompletedNot Applicable
Graftless Lateral Sinus Lifting Using Peizo Electric Device in Patients With Atrophic Maxilla
Egypt30 participantsStarted 2024-07-02
Plain-language summary
Background: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence lateral sinus lifting using surgical guide is used.
Aim of the study: To compare between guided and conventional sinus lifting using piezoelectric device in patients with atrophic maxilla.
Methods: This study will be carried out as a randomized controlled clinical trial; patients will be randomly allocated into two groups: in the study group 15 patients will undergo lateral sinus lifting using surgical guide, while in the control group 15 patients will undergo conventional sinus lifting without surgical guide with simultaneous implant placement.
Clinical evaluation including intraoperative assessment of duration of surgery and immediate complications such as perforation of Schneiderian membrane, arterial laceration and trauma to adjacent roots and nasal bleeding. Primary implant stability will be measured immediately after implant placement
Who can participate
Age range
20 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient seeking replacement of a missed maxillary posterior tooth/ teeth by a delayed dental implant procedure
* Residual bone height is 4-5 mm measured from crestal bone to sinus floor.
* Both genders.
* Good oral hygiene
Exclusion Criteria:
* Recent radiation therapy in maxilla.
* Uncontrolled systemic diseases such as diabetes mellitus.
* Acute/chronic maxillary sinusitis.
* Heavy smoker (those who smoke ≥ 25 cigarettes a day).
* Alcohol abuse.
* Psychosis.
* Severe allergic rhinitis.
* Tumor or large cyst in the maxillary sinus.
* Oroantral fistula.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.